Pandemic Will Limit Role Of US FDA Inspections In Driving FY 2021 Drug GMP Sanctions

Look for alternative approaches like sample testing, remote records review and reliance on trusted host nation authorities to fill many inspection gaps – except for OAI re-inspections. Meanwhile, post-emergency planning begins.